ICD-10-CM Billable Code

H71.31

Diffuse cholesteatosis, right ear

Clinical Classification Guidelines

Medical Intelligence & Overview

Diffuse cholesteatosis of the right ear is a condition characterized by the abnormal growth of skin in the middle ear, leading to the accumulation of keratinizing epithelium. This condition can cause hearing loss, discomfort, and other complications if left untreated. It is a specific type of cholesteatoma, distinguished by its widespread or diffuse nature in the right ear. Recognizing the signs and understanding the underlying causes can help in managing the condition effectively.

Causes & Symptoms

Clinical Causes: Eustachian tube dysfunction, which impairs proper ventilation of the middle ear Previous ear infections or chronic otitis media Trauma or injury to the ear canal or middle ear Congenital anomalies leading to improper development of ear structures Persistent negative pressure in the middle ear causing retraction and skin retention Chronic inflammation and poor ear hygiene that may contribute to abnormal skin growth

Key Symptoms: Gradual hearing loss in the affected ear A feeling of fullness or pressure in the ear Ongoing or intermittent ear discharge, often foul-smelling Ear discomfort or pain, especially if infection develops Sense of hearing distortion or tinnitus (ringing in the ear) Possible balance issues in severe cases

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a thorough medical history and physical examination of the ear by a healthcare professional. The specialist may use otoscopy to visualize the middle ear and observe any abnormal skin growths. Imaging studies, such as CT scans, can provide detailed information about the extent of cholesteatoma and its effects on surrounding structures. Audiometric testing may also be conducted to assess hearing loss. The combination of clinical assessment and imaging helps determine the severity and appropriate course of action.

Treatment Protocols: Treatment options often involve surgical intervention to remove the cholesteatoma and prevent further damage to ear structures. Surgical procedures may include canal wall-up or canal wall-down mastoidectomy, tailored to the extent of disease. Post-operative care may involve antibiotics to control infection and regular follow-up examinations to monitor for recurrence. In some cases, hearing rehabilitation, such as hearing aids or reconstructive surgery, may be recommended to address residual hearing impairment. Early detection and management are crucial to prevent complications like ossicular damage, facial nerve issues, or intracranial infections.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is H71.31 a billable ICD-10 code?
Yes, H71.31 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report H71.31?
Clinical documentation must specify the nature of Diffuse cholesteatosis, right ear and any associated comorbidities for accurate reporting.

Cite this Clinical Reference